Universal-Beteiligungs- und Servicegesellschaft’s Pliant Therapeutics PLRX Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.6K	Hold	18,065	–	–	﹤0.01%	2114
2026 Q1	$22.8K	Hold	18,065	–	–	﹤0.01%	2061
2025 Q4	$22K	Hold	18,065	–	–	﹤0.01%	2044
2025 Q3	$26.7K	Hold	18,065	–	–	﹤0.01%	2082
2025 Q2	$21K	Hold	18,065	–	–	﹤0.01%	2000
2025 Q1	$24.4K	Buy	+18,065	New	+$110K	﹤0.01%	1978

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's PLRX Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft held its Pliant Therapeutics (PLRX) position steady in Q2 2026 at 18,065 shares worth $20.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2114.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in PLRX in Q1 2025 and has held it in 6 quarters since. The position peaked at $26.7K in Q3 2025. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft held 18,065 shares of Pliant Therapeutics worth $20.6K as of Q2 2026.
Universal-Beteiligungs- und Servicegesellschaft left its Pliant Therapeutics share count unchanged in Q2 2026.
Pliant Therapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #2114 holding.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in Pliant Therapeutics in Q1 2025 and has held it in 6 quarters since.
Universal-Beteiligungs- und Servicegesellschaft's Pliant Therapeutics position peaked at $26.7K in Q3 2025.
86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.